HershSagreiyaMD

PubMed

• Liver Imaging Reporting and Data System (LI-RADS) v2018: diagnostic value of ancillary features favoring malignancy in hypervascular observations ≥ 10 mm at intermedia...
  Roberto Cannella, Federica Vernuccio, Hersh Sagreiya, Kingshuk Roy Choudhury, Negaur Iranpour, Daniele Marin, Alessandro Furlan> ;European Radiology. 2020 Feb 27
• 1 citations
  A New Multimodel Machine Learning Framework to Improve Hepatic Fibrosis Grading Using Ultrasound Elastography Systems from Different Vendors.
  Isabelle Durot, Alireza Akhbardeh, Hersh Sagreiya, Andreas M. Loening, Daniel L. Rubin> ;Ultrasound in Medicine and Biology. 2020 Jan 1
• Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single‐Patient Data Meta‐Analysis in More Than 15,000 Individuals
  Elisa Danese, Sara Raimondi, Martina Montagnana, Angela Tagetti, Taimour Y. Langaee, Paola Borgiani, Cinzia Ciccacci, Antonio J. Carcas, Alberto M. Borobia, Hoi Y Tong...> ;Clinical Pharmacology & Therapeutics. 2019 Jun 1
• Point Shear Wave Elastography Using Machine Learning to Differentiate Renal Cell Carcinoma and Angiomyolipoma.
  Hersh Sagreiya, Alireza Akhbardeh, Dandan Li, Rosa Sigrist, Benjamin I. Chung, Geoffrey A. Sonn, Lu Tian, Daniel L. Rubin, Jürgen K. Willmann> ;Ultrasound in Medicine and Biology. 2019 May 25
• Automatic inference of BI-RADS final assessment categories from narrative mammography report findings.
  Imon Banerjee, Selen Bozkurt, Emel Alkim, Hersh Sagreiya, Allison W. Kurian, Daniel L. Rubin> ;Journal of Biomedical Informatics. 2019 Feb 23
• 1 citations
  A multi-model framework to estimate perfusion parameters using contrast-enhanced ultrasound imaging.
  Akhbardeh, A., Sagreiya, H., Kaffas, A. E., Willmann, J. K., Rubin, D. L.> ;Medical physics. 2018 Dec 17
• A radiogenomic analysis of hepatocellular carcinoma: association between fractional allelic imbalance rate index and the liver imaging reporting and data system (LI-RA...
  Alessandro Furlan, Omar Almusa, Robinson K. Yu, Hersh Sagreiya, Amir A. Borhani, Kyongtae T. Bae, J. Wallis Marsh> ;British Journal of Radiology. 2018 Apr 4
• 115 citations
  Genetic variants associated with warfarin dose in African- American individuals: a genome-wide association study
  Minoli A. Perera, Larisa H. Cavallari, Nita A. Limdi, Eric R. Gamazon, Anuar Konkashbaev, Roxana Daneshjou, Anna Pluzhnikov, Dana C. Crawford, Jelai Wang, Nianjun Liu,...> ;The Lancet. 2013 Aug 31
• Pathway analysis of genome-wide data improves warfarin dose prediction
  Roxana Daneshjou, Nicholas P. Tatonetti, Konrad J. Karczewski, Hersh Sagreiya, Stephane Bourgeois, Katarzyna Drozda, James K. Burmester, Tatsuhiko Tsunoda, Yusuke Naka...> ;BMC Genomics. 2013 May 28
• 18 citations
  Impact of the CYP4F2 p.V433M polymorphism on coumarin dose requirement: systematic review and meta-analysis.
  Elisa Danese, Martina Montagnana, Julie A. Johnson, Allan E. Rettie, Carlo-Federico Zambon, Steven A. Lubitz, Guilherme Suarez-Kurtz, Larisa H. Cavallari, L. Zhao, M. ...> ;Clinical Pharmacology & Therapeutics. 2012 Dec 1
• The utility of general purpose versus specialty clinical databases for research: Warfarin dose estimation from extracted clinical variables
  Hersh Sagreiya, Russ B. Altman> ;Journal of Biomedical Informatics. 2010 Oct 1
• 16 citations
  VKORC1 pharmacogenomics summary.
  Ryan P. Owen, Li Gong, Hersh Sagreiya, Teri E. Klein, Russ B. Altman> ;Pharmacogenetics and Genomics. 2010 Oct 1
• 25 citations
  Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9.
  Hersh Sagreiya, Caroline Berube, Alice Wen, Ramesh Ramakrishnan, Alain Mir, Amy Hamilton, Russ B. Altman> ;Pharmacogenetics and Genomics. 2010 Jul 1
• 84 citations
  Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
  Nita A. Limdi, Mia Wadelius, Larisa H. Cavallari, Niclas Eriksson, Dana C. Crawford, Ming Ta Michael Lee, Chien-Hsiun Chen, Alison A. Motsinger-Reif, Hersh Sagreiya, N...> ;Blood. 2010 May 6
• 290 citations
  Clinical assessment incorporating a personal genome
  Euan A. Ashley, Atul J. Butte, Matthew T. Wheeler, Rong Chen, Teri E. Klein, Frederick E. Dewey, Joel T. Dudley, Kelly E. Ormond, Aleksandra Pavlovic, Alexander A. Mor...> ;The Lancet. 2010 May 1
• 1 citations
  A General Framework for Dose Optimization
  Robert G. Turcott, Hersh Sagreiya, Euan A. Ashley, Russ B. Altman, Amar K. Das> ;AMIA ... Annual Symposium proceedings. AMIA Symposium. 2009 Nov 14
• The Double-Anchoring Theory of Lightness Perception: A Comment on Bressan (2006)
  Piers D. L. Howe, Hersh Sagreiya, Dwight L. Curtis, Chengjie Zheng, Margaret S. Livingstone> ;Psychological Review. 2007 Oct 1
• Postscript: a reply to Bressan (2007).
  Howe, P. D., Sagreiya, H., Curtis, D. L., Zheng, C., Livingstone, M. S.> ;Psychol Rev. 2007 Oct
• Join now to see all

Journal Articles

• Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study  
  Perera M.A., Cavallari L.H., Limdi N.A., Gamazon E.R., Konkashbaev A., Daneshjou R., Pluzhnikov A., Crawford D.C., Wang J., Liu N., Tatonetti N., Bourgeois S., Takahas..., The Lancet, 1/1/2013
• Impact of the CYP4F2 pV433M polymorphism on coumarin dose requirement: systematic review and meta-analysis  
  Danese E., Montagnana M., Johnson J.A., Rettie A.E., Zambon C.F., Lubitz S.A., Suarez-Kurtz G., Cavallari L.H., Zhao L., Huang M., Nakamura Y., Mushiroda T., Kringen M..., Clinical Pharmacology and Therapeutics, 1/1/2012
• Clinical evaluation incorporating a personal genome  
  Ashley, E.A., Butte, A.J., Wheeler, M.T., Chen, R., Klein, T.E., Dewey, F.E., Dudley, J.T., Ormond, K.E., Pavlovic, A., Hudgins, L., Gong, L., Hodges, L.M., Berlin, D...., The Lancet, 1/1/2010
• The utility of general purpose versus specialty clinical databases for research: warfarin dose estimation from extracted clinical variables  
  Sagreiya, H., & Altman R.B., Journal of Biomedical Informatics, 1/1/2010
• VKORC1 Pharmacogenomics Summary  
  Owen, R.P., Gong, L., Sagreiya, H., Klein, T.E., Altman, R.B., Pharmacogenetics and Genomics, 1/1/2010
• Warfarin Pharmacogenetics: A single VKORC1 polymorphism is predictive of dose across three racial groups  
  Limdi, N.A., Wadelius, M., Cavallari, L., Eriksson, N., Crawford, D.C., Lee, M.M., Chen, C., Motsinger-Reif, A., Sagreiya, H., Liu, N., Wu, A.H.B, Gage, B.,F., Jorgens..., Blood, 1/1/2010
• Extending and evaluating a warfarin dosing algorithm that includes CYP4F2 and pooled rare variants of CYP2C9  
  Sagreiya, H., Wen, A., Berube, C., Mir, A., Ramakrishnan, R., Hamilton, A., Altman, R.B., Pharmacogenetics and Genomics, 1/1/2010
• An integrative method for scoring candidate genes from association studies: application to warfarin dosing  
  Tatonetti, N.P., Dudley, J.T., Sagreiya, H., Altman, R. B., BMC Bioinformatics, 1/1/2010
• Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data  
  International Warfarin Pharmacogenetics Consortium, New England Journal of Medicine, 1/1/2009
• The Double-anchoring Theory of Lightness Perception: A Comment on Bressan (2006)  
  Howe, P.D.L., Sagreiya, H., Curtis, D.L., Zheng, C., Livingstone, M.S., Psychological Review, 1/1/2007
• Explaining the Footsteps, Bellydancer, Wenceslas, and Kickback Illusions  
  Howe, P.D.L., Thompson, P.G., Anstis, S.M., Sagreiya, H., Livingstone, M. S., Journal of Vision, 1/1/2006
• Join now to see all

Abstracts/Posters

• Quantitative Image Features from 3D Contrast-Enhanced Ultrasound Parametric Maps as Surrogate of Treatment Response
  El Kaffas, A., Sagreiya, H., Hoogi, A., Zhou, J., Hristov, D., Rubin, D., Willmann, J, World Molecular Imaging Conference, New York, NY, 1/1/2016
• 3D Contrast-Enhanced Ultrasound Parametric Map Feature Extraction for Cancer Treatment Monitoring
  El Kaffas, A., Sagreiya, H., Hoogi, A., Zhou, J., Hristov, D., Rubin, D., Willmann, J, Radiological Society of North America, Chicago, IL, 1/1/2016
• Intussusception in an Adult Secondary to Mesenteric Adenitis
  Sagreiya, H., Oppenheimer, J., Kamaya, A., Desser, T.S., ACR Case in Point, 1/1/2012
• Analysis of the WTCCC Dataset Using a Novel Gene-Based Method for Ranking Candidate Genes
  Sagreiya, H., Daneshjou, R., Tatonetti, N., and Altman, R.B, AMIA Summit on Translational Bioinformatics, San Francisco, CA, 1/1/2011
• A Novel Method for Scoring Candidate Genes in Association Studies: Application to Warfarin Response
  Tatonetti, N.P., Dudley, J.T., Sagreiya, H., & Altman, R. B., AMIA Summit on Translational Bioinformatics, San Francisco, CA, 1/1/2010
• Extending and Evaluating Warfarin Pharmacogenetic Algorithms Using CYP4F2 and Rare Variants in CYP2C9
  Sagreiya, H., Berube, C., Wen, A., Ramakrishnan, R., Mir, A., Hamilton, A., & Altman, R.B, American College of Physicians: Internal Medicine; Howard Hughes Medical Institute: Meeting of Medical Fellows, Toronto, Canada, 2010; Bethesda, MD, 2010, 1/1/2010
• Differences in Antipsychotic Adverse Events among Adult, Pediatric, and Geriatric Populations - An Analysis of the FDA Adverse Events Reporting System
  Kumarasamy, N., Sagreiya, H., Chen, Y., Ponnusamy, K., Das, A, Biomedical Computation at Stanford, Palo Alto, CA, 1/1/2010
• A General Framework for Dose Optimization
  Turcott, R.G., Sagreiya, H., Altman, R.B., Das, A.K, AMIA Annual Symposium Proceedings, 1/1/2009
• Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
  Sagreiya, H., on behalf of the International Warfarin Pharmacogenetics Consortium, AMIA Summit on Translational Bioinformatics, San Francisco, CA, 1/1/2009
• Evaluating Warfarin Pharmacogenetic Algorithms via an Analysis Factors Involved in its Dosing and Stability
  Sagreiya, H., Wen, A., Berube, C., Mir, A., Ramakrishnan, R., Hamilton, A., & Altman, R.B., 10th National Conference on Anticoagulant Therapy, San Diego, CA, 1/1/2009
• Evaluation of Clinical and Pharmacogenetic Factors Involved in Warfarin Dosing
  Sagreiya, H., Altman, R.B, Biomedical Computation at Stanford, Palo Alto, CA, 1/1/2008
• Rapid Screening of Genetic Factors Associated with Warfarin Dosage Using a Nanofluidic System
  Ramakrishnan, R., Mir, A., Hamilton, A., Sagreiya, H., & Altman, R.B., American Society of Human Genetics, Philadelphia, PA, 1/1/2008
• The Pharmacogenomics of Warfarin Dosing
  Sagreiya, H., Altman, R.B, Pharmacogenomics, Cold Spring Harbor, NY, 1/1/2008
• Explaining the Footsteps, Bellydancer, Wenceslas, and Kickback Illusions
  Howe, P.D.L., Thompson, P.G., Anstis, S.M., Sagreiya, H., & Livingstone, M.S., Vision Sciences Society, Sarasota, FL, 1/1/2007
• Disputing the Leading and Trailing Edge Explanation of the Footsteps Illusion
  Sagreiya, H., Howe, P.D.L. & Livingstone, M.S., Tenth International Conference on Cognitive and Neural Systems, Boston, MA, 1/1/2006
• The effect of prevalence of disease on performance of residents and fellows during training for interpreting DBT in a test-train-test observer study
  Hakim, C.M., Chang Sen, L., Degnan, A., Delic, J., Pai, S., Sagreiya, H., Sparrow, M., Thomas, E., Yannes, M., Gur, D, SPIE Medical Imaging
• Join now to see all